MetaCap

Kailera Therapeutics Statistics

NASDAQ: KLRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.02-0.56 (-4.84%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Kailera Therapeutics by the numbers

Kailera Therapeutics has a market capitalization of $1.43 billion based on 129.85M shares outstanding. With trailing EPS of $-4.16, Kailera Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.8% below its 50-day average and 36.9% below its 200-day average.

Average daily trading volume is 1.08M shares, or about $11.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

KLRA valuation vs. peer median

KLRA compared with the median of 8 peer companies
MetricKLRAPeer medianDifference
Market cap$1.43B$1.40B+2%
Avg. volume1.08M821.59K+31%

Peer median across 8 companies: SRPT, DMRA, ADRX, NRIX, TYRA, ANAB, RAPP, QURE.

Valuation

Price and trading

Previous close
11.58
Open
11.29
Day range
11.00 – 11.87
52-week range
9.76 – 28.23
Beta
—
Volume
553.23K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.43B
Forward Pe
-2.84
Eps
-4.16
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
28.23
Week52 Low
9.76
Avg Volume
1.08M
Shares Outstanding
129.85M
Ma50
12.22
Ma200
17.46
Earnings Date
Nov 4, 2026
Pct From52w High
-60.96%
Pct From52w Low
12.91%

Related